Precigen Inc (PGEN) Stock Price, Quote & News

Company Profile

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell t...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 556 9900

Website: precigen.com

Address:

20374 Seneca Meadows Parkway, Germantown, United States

RubiDunceclownshow Apr. 5 at 9:59 AM

$PGEN your president is shorting the market ,, you stupid fuck

0 · Reply

updownsides Apr. 5 at 7:16 AM

$PGEN Wow! I realized the management team was good by how fast Papzimeos came to be, but the credentials are outstanding. Click on these 2 professionals link and see for yourself the experience they brought. There's little doubt now that Prgn-2009 could be a diamond in the rough with a much larger TAM in multiple indications. https://www.linkedin.com/posts/precigen_hbarisingstar-hbaluminary-activity-7444730239332761600-NOWw?utm_source=share&utm_medium=member_android&rcm=ACoAABjU1vcBkrQkSc4MCRE_HtR_gs_Gssrdfko

1 · Reply

dsup Apr. 3 at 1:03 PM

$PGEN correct me if i’m wrong but we should expect EU decision by october 2026. with that said a partner for the EU expansion (which has been mentioned by helen multiple times) would happen before the approval?

2 · Reply

chungana Apr. 3 at 8:20 AM

$PGEN Did management say next earnings call will be in May? TIA.

1 · Reply

Golfer109 Apr. 2 at 10:39 PM

$PGEN The YouTube video said the likely of the EU deal will be mid next year. I don't know if that's right or wrong, but that's what they said

0 · Reply

Wacousta Apr. 2 at 2:55 PM

$PGEN EU announcement coming?

4 · Reply

dsup Apr. 2 at 1:21 AM

$INO $PGEN bingo bango

1 · Reply

dsup Apr. 2 at 1:17 AM

$PGEN https://www.stocktitan.net/news/INO/inovio-announces-proposed-public-j2k366xueltf.html

0 · Reply

M22 Apr. 1 at 11:16 PM

$PGEN 👀 https://youtu.be/I9YKRZOjEYs?si=MAC-eJFUE7JpfXPz

1 · Reply

Norny44 Apr. 1 at 8:11 PM

$PGEN j-code from today. Would it have been advantage to declare this as a PR on it's own ?. I know it was already disclosed but this is quite a big deal.

0 · Reply

Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript

Mar 30, 2026, 8:30 AM EDT - 5 days ago

Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31

Mar 26, 2026, 1:57 PM EDT - 9 days ago

Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has)

Mar 26, 2026, 12:08 PM EDT - 9 days ago

These Analysts Boost Their Forecasts On Precigen Following Q4 Results

Mar 25, 2026, 6:56 PM EDT - 10 days ago

Precigen, Inc. (PGEN) Q4 2025 Earnings Call Transcript

Mar 25, 2026, 4:05 PM EDT - 10 days ago

Precigen Reports Full Year 2025 Financial Results and Business Updates

Mar 11, 2026, 4:05 PM EDT - 24 days ago

Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

Feb 11, 2026, 9:34 AM EST - 7 weeks ago

Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech

Jan 20, 2026, 8:05 AM EST - 2 months ago

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis

Jan 15, 2026, 12:55 PM EST - 2 months ago

Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 8:00 AM EST - 2 months ago

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:05 PM EST - 3 months ago

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 25, 2025, 6:51 AM EST - 4 months ago

Precigen Is Still A Buy After The Papzimeos Rally

Nov 13, 2025, 10:51 PM EST - 5 months ago

Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:05 PM EST - 5 months ago

Precigen Reports Third Quarter 2025 Financial Results and Business Updates

Nov 6, 2025, 4:30 PM EST - 5 months ago

Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13

Oct 13, 2025, 7:00 AM EDT - 6 months ago

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis

Sep 3, 2025, 7:00 AM EDT - 7 months ago

Precigen Announces Up to $125 Million Non-Dilutive Financing

Sep 2, 2025, 1:55 PM EDT - 7 months ago

Precigen, Inc. - Special Call

Aug 25, 2025, 8:05 AM EDT - 7 months ago

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright

Aug 22, 2025, 10:43 AM EDT - 8 months ago

Undercovered Dozen: Precigen, ONEOK, Bitmine And More

BMNR OKE

Aug 15, 2025, 3:15 PM EDT - 8 months ago

Precigen: This Billion-Dollar Approval Is Still Undervalued

Aug 15, 2025, 9:48 AM EDT - 8 months ago

Why Is Precigen Stock Surging On Friday?

Aug 15, 2025, 7:18 AM EDT - 8 months ago

US FDA approves Precigen's immunotherapy for rare respiratory disease

Aug 15, 2025, 7:00 AM EDT - 8 months ago

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Jul 7, 2025, 5:58 PM EDT - 9 months ago

Precigen: August Is Pivotal For This Biotech Innovator

May 14, 2025, 4:05 PM EDT - 11 months ago

Precigen Reports First Quarter 2025 Financial Results and Business Updates

Apr 16, 2025, 8:05 AM EDT - 1 year ago

Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th

Mar 19, 2025, 7:47 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:05 PM EDT - 1 year ago

Precigen Reports Full Year 2024 Financial Results and Business Updates

Mar 13, 2025, 8:05 AM EDT - 1 year ago

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th

Feb 28, 2025, 8:56 AM EST - 1 year ago

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement

Feb 25, 2025, 8:05 AM EST - 1 year ago

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025

Jan 13, 2025, 7:00 AM EST - 1 year ago

Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 8:30 AM EST - 1 year ago

Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 7:00 AM EST - 1 year ago

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Dec 27, 2024, 9:00 AM EST - 1 year ago

Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

Nov 14, 2024, 4:30 PM EST - 1 year ago

Precigen Reports Third Quarter 2024 Financial Results and Business Updates

Nov 12, 2024, 4:05 PM EST - 1 year ago

Precigen to Participate in the Stifel 2024 Healthcare Conference

Sep 16, 2024, 4:30 PM EDT - 1 year ago

Precigen to Participate in the 2024 Cantor Global Healthcare Conference

Aug 15, 2024, 8:11 AM EDT - 1 year ago

Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session

GGR TITN

Aug 14, 2024, 7:03 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th

Aug 7, 2024, 9:30 PM EDT - 1 year ago

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock

Aug 6, 2024, 4:04 PM EDT - 1 year ago

Precigen Announces Proposed $30 Million Public Offering of Common Stock

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch

Jul 23, 2024, 8:01 AM EDT - 1 year ago

Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

Jun 3, 2024, 9:30 AM EDT - 1 year ago

Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response

May 23, 2024, 5:00 PM EDT - 2 years ago

Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting

RubiDunceclownshow Apr. 5 at 9:59 AM

$PGEN your president is shorting the market ,, you stupid fuck

0 · Reply

updownsides Apr. 5 at 7:16 AM

1 · Reply

dsup Apr. 3 at 1:03 PM

2 · Reply

chungana Apr. 3 at 8:20 AM

$PGEN Did management say next earnings call will be in May? TIA.

1 · Reply

Golfer109 Apr. 2 at 10:39 PM

$PGEN The YouTube video said the likely of the EU deal will be mid next year. I don't know if that's right or wrong, but that's what they said

0 · Reply

Wacousta Apr. 2 at 2:55 PM

$PGEN EU announcement coming?

4 · Reply

dsup Apr. 2 at 1:21 AM

$INO $PGEN bingo bango

1 · Reply

dsup Apr. 2 at 1:17 AM

$PGEN https://www.stocktitan.net/news/INO/inovio-announces-proposed-public-j2k366xueltf.html

0 · Reply

M22 Apr. 1 at 11:16 PM

$PGEN 👀 https://youtu.be/I9YKRZOjEYs?si=MAC-eJFUE7JpfXPz

1 · Reply

Norny44 Apr. 1 at 8:11 PM

$PGEN j-code from today. Would it have been advantage to declare this as a PR on it's own ?. I know it was already disclosed but this is quite a big deal.

0 · Reply

Winthorpe3 Apr. 1 at 4:55 PM

$PGEN any other drugs that they will be able to monetize? Any of the cancer drugs have potential? Seemed to pause on that. Can the gorilla vector stuff be used for other areas?

0 · Reply

chungana Apr. 1 at 4:25 PM

$PGEN Just need Hegseth to authorize an Apache helicopter flyover of Precigen headquarters and we’ll be at $5 in no time! 🫡

0 · Reply

blue_horseshoe_9P Apr. 1 at 12:02 PM

$PGEN This is going to be a battle at $4 today. We have a very bullish setup but the shorts are a resilient bunch here and will make a stand. If we can break through look out!!

0 · Reply

chungana Apr. 1 at 6:40 AM

$PGEN Will Hegseth buy Precigen today after getting insider info about ”guerilla warfare” in Iran and make price go up more today? 😅

1 · Reply

BetweenYourStocks Apr. 1 at 6:37 AM

$PGEN April looking to be very bullish here. Chart looks great.

0 · Reply

Stock_Catcher Apr. 1 at 1:21 AM

New Video out on the Bullish Analysis on $QCLS $ASTI $PGEN $SNSE $IVF and More https://www.youtube.com/watch?v=vckxxSleOtY

0 · Reply

chungana Mar. 31 at 10:19 PM

$PGEN Let’s hope the CEO buys a few million Trump Coin tomorrow to keep this rally going! 🤞

0 · Reply

Wacousta Mar. 31 at 9:07 PM

$PGEN FYI FORM 4 KIRK https://investors.precigen.com/node/14881/html

0 · Reply

Wacousta Mar. 31 at 8:07 PM

$PGEN FYI https://investors.precigen.com/node/14876/html

1 · Reply

dsup Mar. 31 at 8:00 PM

$PGEN strong close

0 · Reply

Few_erish Mar. 31 at 7:42 PM

$PGEN buyers keep showing up

1 · Reply

Kpax4OSU Mar. 31 at 6:45 PM

$PGEN May claim $4 again today. Should never have dipped below anyways IMO. Glad I added in the low $3's!

0 · Reply

Market Cap	1.39B
Revenue (ttm)	9.68M
Net Income (ttm)	-250.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	196.50
Profit Margin	-2,589.26%
Debt to Equity Ratio	4.46

Volume	5,457,900
Avg Vol	5,009,344
Day's Range	N/A - N/A
Shares Out	353.93M
Stochastic %K	73%
Beta	1.12
Analysts	Sell
Price Target	$9.50